OECD · Health

Czechia: Pharmaceutical sales: Antiinfectives for systemic use, US dollars per person, PPP converted

81.80US dollars per person, PPP converted · 2024+69.4% since 2014

OECD dataflow OECD.ELS.HD:HEALTH_PHMC@DF_PHMC_SALES. Pharmaceutical sales: Antiinfectives for systemic use (US dollars per person, PPP converted). Annual figures for Czechia from 2000 to 2024.

20002024

Every year

YearValue (US dollars per person, PPP converted)Note
202481.8
202389.3
202270.7
202162.1
202060.3
201971.9
201863.3
201757.9
201654.3
201549.1
201448.3
201348.9
201253.1
201154.7
201049.8
200949.9
200840.6
200733.6
200630.1
200532.5
200428
200328.9
200227.4
200126.1
200022.1

Source

Published by OECD, produced by OECD. Licence: OECD terms (CC BY 4.0). Retrieved 2026-11-17.

The dataset for every country, with quality and provenance →

Cite or download

OECD (2026). Pharmaceutical sales: Antiinfectives for systemic use, US dollars per person, PPP converted. Interva. https://interva.co/dataset/oecd-df-phmc-sales-ph-sales-z-j-usd-ppp-ps (accessed 2026-11-21). catalog snapshot 2026-11-17.

JSON, CzechiaAPI and MCP

Pharmaceutical sales: Antiinfectives for systemic use, US dollars per person, PPP converted in other countries

Rank Czechia against its region, see where publishers disagree, or ask a question in plain words on the Interva desk.

Czechia: Pharmaceutical sales: Antiinfectives for systemic use, US dollars per person, PPP converted (2000–2024) · Interva